YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Smad4 and p53 synergize in suppressing autochthonous intestinal cancer	CANCER MEDICINE
2022	Suggestion of cystatin C indication using muscle mass-based parameter for the desirable prediction of glomerular filtration rate	CLINICA CHIMICA ACTA
2022	The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis	GUT AND LIVER
2022	Durvalumab +/− Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase III POSEIDON Study	PNEUMOLOGIE
2022	Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease	GUT AND LIVER
2022	Poziotinib for HER2-positive metastatic breast cancer (MBC): Final clinical efficacy and safety results for long-term follow-up of the phase II NOV120101-203 trial	ANNALS OF ONCOLOGY
2022	Phase III study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)	ANNALS OF ONCOLOGY
2022	Validation and clinical application of a novel platelet function analyzer (ANYSIS 200) in cardiology patients	CLINICA CHIMICA ACTA
2022	Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer	CANCERS
2022	Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone	CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2022	Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study	LANCET GASTROENTEROLOGY & HEPATOLOGY
2022	Change in management and outcome of mechanical ventilation in Korea: a prospective observational study	KOREAN JOURNAL OF INTERNAL MEDICINE
2022	Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis	CRITICAL CARE
2022	Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2022	Effects of the Discharge Education Program on Family Caregivers Caring for Patients on Mechanical Home Ventilation in Korea: A Pilot Test	HOME HEALTH CARE MANAGEMENT AND PRACTICE
2022	The effect of scan and patient parameters on the diagnostic performance of AI for detecting coronary stenosis on coronary CT angiography	CLINICAL IMAGING
2022	The effect of polycyclic aromatic hydrocarbons on changes in the brain structure of firefighters: An analysis using data from the Firefighters Research on Enhancement of Safety & Health study	SCIENCE OF THE TOTAL ENVIRONMENT
2022	Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys)	STEM CELL RESEARCH
2022	Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways	BMC CANCER
2022	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry	TUBERCULOSIS AND RESPIRATORY DISEASES